Latest Franking News

GWA Group Limited reported modest revenue and profit growth for FY2025, driven by disciplined execution amid challenging markets. The company raised its dividend and announced a $30 million on-market share buyback, underscoring confidence in its financial position.

Aurizon Holdings reported a 3% decline in underlying EBITDA and a 14% drop in NPAT for FY2025, while unveiling a $150 million on-market buy-back and a $500 million subordinated notes issuance to strengthen its balance sheet.

Aurizon reported a slight decline in FY2025 underlying EBITDA to $1.576 billion but secured a landmark BHP contract and announced a fresh $150 million buy-back, signaling confidence in its future growth.

Aurizon Holdings Limited has announced a fully franked ordinary dividend of AUD 0.065 per share for the six months ending June 2025, payable in September.

Aurizon Holdings reported a modest 3% decline in FY2025 underlying EBITDA, weighed down by Bulk segment setbacks, while announcing a robust FY2026 earnings forecast and a $150 million share buy-back.

Ampol Limited has announced a fully franked ordinary dividend of AUD 0.40 per share for the six months ending June 2025, signaling steady returns for shareholders.

Ampol Limited reported a resilient first half of 2025 with $649 million RCOP EBITDA and a strategic push into EV charging and renewable fuels. The company declared a fully franked 40 cents per share interim dividend, underscoring confidence in its growth trajectory.

Ampol Limited reported a resilient first half in 2025 with steady earnings and declared a fully franked interim dividend, while announcing a transformative acquisition of EG Australia pending regulatory approval.

Ampol Limited posted a statutory net loss of $25.3 million for the first half of 2025, impacted by significant items and inventory losses, while continuing to invest in electric vehicle infrastructure and fuel supply chain enhancements.

Fiducian Group reported robust FY2025 results, showcasing significant growth in funds under management and administration alongside a strong dividend payout. The company’s fintech innovation and adviser expansion underpin its steady momentum.

Fiducian Group Limited has reported a solid 23.5% rise in net profit for the 2025 financial year, alongside a 10.6% increase in revenue and a higher fully franked final dividend of 24.7 cents per share.

ResMed Inc has updated the foreign exchange rate for its forthcoming dividend payable to ASX-listed CDIs, setting the Australian dollar payout at 9.24 cents per CDI. This adjustment reflects the latest USD to AUD exchange rate and carries important tax implications for investors.